Insight that Keeps You a Beat Ahead.

HeartLogic is the first and only heart failure diagnostic validated to have high sensitivity, the ability to provide weeks of advanced notice, and low alert burden for detecting indications of worsening heart failure.1

AVAILABLE EXCLUSIVELY IN THE RESONATE™ FAMILY OF CRT-Ds AND ICDs >


Industry Breakfast Contemporary Forum
Gaylord Opryland Resort and Convention Center
Nashville, TN
A Multi-Sensor Heart Failure Diagnostic -
Clinical Evidence and Practical Consideration
Sunday, September 16, 2018 • 6:45am - 7:45am
Experts will discuss clinical data supporting the HeartLogic diagnostic, share early experience with HeartLogic alerts, illustrate how HeartLogic can help risk stratify patients and provide best practices for integrating HeartLogic into clinical practice.


Moderator

JoAnn Lindenfeld, MD
Director, Advanced Heart Failure/
Cardiac Transplantation
Vanderbilt University Medical Center
Nashville, TN

Hi

John Boehmer, MD
Professor of Medicine
Penn State College of Medicine
Heart Failure Program Director
Penn State Hershey Medical Center
Hershey, PA

Panel Faculty

Seth Rials, MD, PhD
Medical Director of Arrhythmia Services
Grant Medical Center
OhioHealth Heart and Vascular Physicians
Columbus, OH

Panel Faculty

Marie Galvao, MSN, ANP-BC, CHFN
Center for Advanced Cardiac Therapy
Montefiore Medical Center
Bronx, NY

Plan Your HFSA Data Dive.

Evidence continues to build for the FDA-approved HeartLogic Heart Failure Diagnostic – a device-based diagnostic that measures multiple physiological trends to predict worsening heart failure.1

HFSA Abstract Data Releases
Top